Sexual dimorphism in the lasting effects of moderate caloric restriction during gestation on energy homeostasis in rats is related with fetal programming of insulin and leptin resistance.
OBJECTIVE
We aimed to characterize the lasting effect of moderate caloric restriction during early pregnancy on offspring energy homeostasis, by focusing on the effects on food intake and body weight as well as on the insulin and leptin systems.


METHODS
Male and female offspring of 20% caloric restricted dams (from 1 to 12 days of pregnancy) (CR) and from control dams were studied. These animals were fed after weaning with a normal-fat (NF) diet until the age of 4 months, and then moved to a high-fat (HF) diet. Blood parameters were measured under fed and 14-h fasting conditions at different ages (2, 4 and 5 months). Food preferences were also assessed in adult animals.


RESULTS
Accumulated caloric intake from weaning to the age of 5 months was higher in CR animals compared with their controls, and this resulted in higher body weight in adulthood in males, but not in females. Both male and female CR animals already showed higher insulin levels at the age of 2 months, under fed conditions, and higher HOMA-IR from the age of 4 months, compared with their controls. CR male animals, but not females, displayed higher preference for fat-rich food than their controls in adulthood and higher circulating leptin levels when they were under HF diet.


CONCLUSIONS
It is suggested that hyperinsulinemia may play a role in the etiology of hyperphagia in the offspring of caloric restricted animals during gestation, with different outcomes on body weight depending on the gender, which could be associated with different programming effects on later leptin resistance.
Palou
Mariona
M
Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), University of the Balearic Islands (UIB) and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Palma de Mallorca, Spain. andreu.palou@uib.es.
Priego
Teresa
T
Sánchez
Juana
J
Palou
Andreu
A
Picó
Catalina
C
Diabetes Obes Metab. 2010 May;12(5):403-13
20415688
Am J Physiol Regul Integr Comp Physiol. 2002 Oct;283(4):R941-8
12228064
Mol Cell Endocrinol. 2001 Dec 20;185(1-2):73-9
11738796
Metab Syndr Relat Disord. 2009 Oct;7(5):447-52
19419266
J Pharmacol Exp Ther. 2003 Nov;307(2):544-9
12966151
J Nutr. 1993 Aug;123(8):1421-8
8336213
Endocrinology. 2010 Mar;151(3):1030-41
20068006
Nature. 2000 Apr 6;404(6778):661-71
10766253
Pflugers Arch. 2001 Jun;442(3):383-90
11484769
Science. 1982 Mar 19;215(4539):1518-9
7063860
Lipids. 2003 Feb;38(2):103-8
12733740
Diabetologia. 1993 Jan;36(1):62-7
8436255
Diabetologia. 1985 Jul;28(7):412-9
3899825
J Perinat Med. 2004;32(4):297-305
15346812
N Engl J Med. 1976 Aug 12;295(7):349-53
934222
Br J Nutr. 2004 Sep;92(3):513-20
15469656
J Endocrinol. 2006 May;189(2):355-63
16648302
Endocr Rev. 1992 Aug;13(3):387-414
1425482
Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):146-52
19171470
Int J Obes Relat Metab Disord. 2002 Jul;26(7):973-7
12080452
J Clin Endocrinol Metab. 1997 Feb;82(2):402-6
9024226
Genes Nutr. 2009 Jun;4(2):151-6
19277751
Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E83-7
10893326
Exp Gerontol. 2009 Jan-Feb;44(1-2):20-5
18572339
Front Biosci. 2007 May 01;12:3531-44
17485319
Endocrinology. 2008 Feb;149(2):733-40
17991728
Diabetes. 2006 Apr;55(4):978-87
16567519
Health Rep. 1994;6(1):45-53
7919088
Metab Syndr Relat Disord. 2006 Summer;4(2):129-37
18370759
Clin Chim Acta. 2007 Jan;375(1-2):20-35
16956601
Ann N Y Acad Sci. 2002 Jun;967:52-65
12079835
Public Health Nutr. 2001 Apr;4(2B):611-24
11683554
Horm Behav. 2009 Jan;55(1):33-40
18718472
Int J Obes Relat Metab Disord. 2002 Mar;26(3):318-26
11896486
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1344-8
15314628
Diabetes. 2003 Mar;52(3):682-7
12606509
Int J Obes (Lond). 2007 Aug;31(8):1199-209
17356529